1. Home
  2. IRON vs STEL Comparison

IRON vs STEL Comparison

Compare IRON & STEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$70.47

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Stellar Bancorp Inc.

STEL

Stellar Bancorp Inc.

HOLD

Current Price

$37.46

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
STEL
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
IRON
STEL
Price
$70.47
$37.46
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
$103.18
$37.00
AVG Volume (30 Days)
356.5K
284.5K
Earning Date
05-06-2026
04-24-2026
Dividend Yield
N/A
1.59%
EPS Growth
N/A
N/A
EPS
N/A
1.99
Revenue
N/A
$6,282,000.00
Revenue This Year
N/A
$10.14
Revenue Next Year
$283.52
$4.65
P/E Ratio
N/A
$18.91
Revenue Growth
N/A
N/A
52 Week Low
$39.20
$24.59
52 Week High
$99.50
$40.21

Technical Indicators

Market Signals
Indicator
IRON
STEL
Relative Strength Index (RSI) 64.19 59.65
Support Level $57.79 $34.99
Resistance Level $82.70 $40.21
Average True Range (ATR) 2.83 0.53
MACD 1.07 0.17
Stochastic Oscillator 96.17 80.73

Price Performance

Historical Comparison
IRON
STEL

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc. and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

Share on Social Networks: